Bogossian Harilaos, Steinfurt Johannes, Robl Sebastian, Bimpong-Buta Nana-Yaw, Iliodromitis Konstantinos, Lemke Bernd
Klinik für Kardiologie und Rhythmologie, Evangelisches Krankenhaus Hagen, Brusebrinkstr. 20, 58135, Hagen, Deutschland.
Universität Witten-Herdecke, Witten, Deutschland.
Herzschrittmacherther Elektrophysiol. 2023 Jun;34(2):109-113. doi: 10.1007/s00399-023-00943-6. Epub 2023 Apr 28.
The cardiac implantable electronic device (CIED) is the therapy of choice for management of symptomatic bradyarrhythmias. However, the indication for CIED implantation in the cases of asymptomatic bradycardias should be carefully individualized. Incidental electrocardiographic findings in asymptomatic patients (e.g., low baseline heart rates, higher than first-degree atrioventricular block or longer pauses) may complicate the physician's decision regarding the necessity of CIED implantation. The main reason is the inherit risk of short- and long-term complications with every CIED implantation, i.e., peri-operative complications, risk of CIED infection, lead fractures, and the necessity for lead extraction. Therefore, before opting for, or against, CIED implantation, several factors should be considered in the subset of asymptomatic patients.
心脏植入式电子设备(CIED)是治疗有症状性缓慢性心律失常的首选疗法。然而,对于无症状性心动过缓患者植入CIED的指征应谨慎个体化。无症状患者的偶然心电图发现(例如,基础心率低、高于一度房室传导阻滞或更长的间歇)可能使医生关于CIED植入必要性的决定变得复杂。主要原因是每次CIED植入都存在短期和长期并发症的固有风险,即围手术期并发症、CIED感染风险、导线断裂以及导线拔除的必要性。因此,在决定是否植入CIED之前,对于无症状患者亚组应考虑几个因素。